COVID-19 and SLE patients share many common hub genes, related pathways and regulatory networks. Based on these common targets, we found many potential drugs that could be used in treating patient with COVID-19 or COVID-19 combined with SLE.
Keyphrases
- coronavirus disease
- systemic lupus erythematosus
- sars cov
- disease activity
- end stage renal disease
- respiratory syndrome coronavirus
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- transcription factor
- case report
- dna methylation
- human health
- bioinformatics analysis
- drug induced